Abstract
Purpose
Conventional ultrasound is the main imaging modality in obstetrics for assessing the maternal and fetal status. Up to date, contrast-enhanced ultrasound (CEUS) has not found widespread use in gynecology and obstetrics, but recent studies demonstrate promising results. The aim of the present study is to assess safe and valuable application of CEUS during pregnancy to investigate non-obstetric conditions.
Methods
Five pregnant patients on whom CEUS was performed between 2019 and 2020 were included in this retrospective single-center study. A total of six CEUS examinations were performed including one CEUS-guided biopsy (mean age: 31 years, mean weeks of pregnancy: 18 weeks). CEUS examinations were performed by a consultant radiologist (EFSUMB level 3).
Results
All included pregnant women safely underwent CEUS. Neither maternal nor fetal adverse effects were detected. CEUS critically helped in the diagnostic workup of a desmoid tumor of the abdominal wall, hepatic hemangioma, amebic hepatic abscess, uncomplicated renal cyst and post-inflammatory alteration of the renal cortex and for excluding active abdominal bleeding. In addition, CEUS-guided biopsy was performed to prevent intratumoral hemorrhage. Findings from CEUS prompted immediate treatment in two women, whereas in three women regular obstetric monitoring of the women could be conducted.
Conclusion
Our results demonstrate safe and crucial application of off-label CEUS in pregnant women to assess different non-obstetric conditions allowing to prevent additional ionizing CT or application of (gadolinium-based) contrast agent in MRI. Hence, CEUS might add pivotal value for evaluating obstetric and non-obstetric conditions and thereby directing clinical management of pregnant women in the future.
Similar content being viewed by others
Abbreviations
- CEUS:
-
Contrast-enhanced ultrasound
- CT:
-
Computed tomography
- GBCA(s):
-
Gadolinium-based contrast agent(s)
- MRI:
-
Magnetic resonance imaging
References
Salomon LJ, Alfirevic Z, Bilardo CM, Chalouhi GE, Ghi T, Kagan KO et al (2013) ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 41(1):102–113
Abramowicz JS (2013) Benefits and risks of ultrasound in pregnancy. Semin Perinatol 37(5):295–300
Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E et al (2018) The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med 39(2):e2–e44
Poret-Bazin H, Simon EG, Bleuzen A, Dujardin PA, Patat F, Perrotin F (2013) Decrease of uteroplacental blood flow after feticide during second-trimester pregnancy termination with complete placenta previa: quantitative analysis using contrast-enhanced ultrasound imaging. Placenta 34(11):1113–1115
Windrim R, Kingdom J, Jang HJ, Burns PN (2016) Contrast enhanced ultrasound (CEUS) in the prenatal evaluation of suspected invasive placenta percreta. J Obstet Gynaecol Can 38(10):975–978
Xiong X, Yan P, Gao C, Sun Q, Xu F (2016) The value of contrast-enhanced ultrasound in the diagnosis of Cesarean scar pregnancy. Biomed Res Int 2016:4762785
Gassert F, Schnitzer M, Kim SH, Kunz WG, Ernst BP, Clevert DA, et al (2020) Comparison of magnetic resonance imaging and contrast-enhanced ultrasound as diagnostic options for unclear cystic renal lesions: a cost-effectiveness analysis. Ultraschall Med. 2020.
Rubenthaler J, Kim SH, Kunz WG, Sommer WH, Trottmann M, Clevert DA, et al (2019) Should we use contrast-enhanced ultrasound (CEUS) for the characterization of nonpalpable testicular lesions? An analysis from a cost-effectiveness perspective. Ultraschall Med. 2019.
Piscaglia F, Bolondi L, Italian Society for Ultrasound in M, Biology Study Group on Ultrasound Contrast A (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369–1375.
Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK (2007) Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics 27(6):1705–1722
Lazarus E, Debenedectis C, North D, Spencer PK, Mayo-Smith WW (2009) Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients—1997–2006. Radiology 251(2):517–524
Williams PM, Fletcher S (2010) Health effects of prenatal radiation exposure. Am Fam Physician 82(5):488–493
Committee on Obstetric P (2017) Committee opinion no. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 130(4):e210–e216.
Mervak BM, Altun E, McGinty KA, Hyslop WB, Semelka RC, Burke LM (2019) MRI in pregnancy: indications and practical considerations. J Magn Reson Imaging 49(3):621–631
Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in M (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 16(7):564–570.
Prola-Netto J, Woods M, Roberts VHJ, Sullivan EL, Miller CA, Frias AE et al (2018) Gadolinium chelate safety in pregnancy: barely detectable gadolinium levels in the juvenile nonhuman primate after in utero exposure. Radiology 286(1):122–128
Khairinisa MA, Takatsuru Y, Amano I, Erdene K, Nakajima T, Kameo S et al (2018) The effect of perinatal gadolinium-based contrast agents on adult mice behavior. Invest Radiol 53(2):110–118
Ariyani W, Iwasaki T, Miyazaki W, Khongorzul E, Nakajima T, Kameo S et al (2016) Effects of gadolinium-based contrast agents on thyroid hormone receptor action and thyroid hormone-induced cerebellar Purkinje cell morphogenesis. Front Endocrinol (Lausanne) 7:115
Abramowicz JS, Barnett SB, Duck FA, Edmonds PD, Hynynen KH, Ziskin MC (2008) Fetal thermal effects of diagnostic ultrasound. J Ultrasound Med 27(4):541–559; quiz 60–63.
Carstensen EL (1987) Acoustic cavitation and the safety of diagnostic ultrasound. Ultrasound Med Biol 13(10):597–606
Suhr D, Brummer F, Irmer U, Wurster C, Eisenmenger W, Hulser DF (1996) Bioeffects of diagnostic ultrasound in vitro. Ultrasonics 34(2–5):559–561
Barnett SB, ter Haar GR, Ziskin MC, Nyborg WL, Maeda K, Bang J (1994) Current status of research on biophysical effects of ultrasound. Ultrasound Med Biol 20(3):205–218
Graham JM Jr, Edwards MJ, Edwards MJ (1998) Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans. Teratology 58(5):209–221
Denbow ML, Blomley MJ, Cosgrove DO, Fisk NM (1997) Ultrasound microbubble contrast angiography in monochorionic twin fetuses. Lancet 349(9054):773
Denbow ML, Welsh AW, Taylor MJ, Blomley MJ, Cosgrove DO, Fisk NM (2000) Twin fetuses: intravascular microbubble US contrast agent administration—early experience. Radiology 214(3):724–728
Arthuis CJ, Novell A, Escoffre JM, Patat F, Bouakaz A, Perrotin F (2013) New insights into uteroplacental perfusion: quantitative analysis using Doppler and contrast-enhanced ultrasound imaging. Placenta 34(5):424–431
Schwarze V, Marschner C, Negrao de Figueiredo G, Rubenthaler J, Clevert DA (2019) Single-center study: evaluating the diagnostic performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions. Ultraschall Med. 2019.
Hua X, Zhu LP, Li R, Zhong H, Xue YF, Chen ZH (2009) Effects of diagnostic contrast-enhanced ultrasound on permeability of placental barrier: a primary study. Placenta 30(9):780–784
Schwarze V, Marschner C, Negrao de Figueiredo G, Mueller-Peltzer K, Neumann J, Rubenthaler J, et al (2019) SonoVue(R) does not appear to cross the placenta as observed during an examination aimed at confirming a diagnosis of liver echinococcosis in a pregnant woman. Ultraschall Med. 2019.
Sidhu PS, Huang DY, Fang C (2020) Contrast enhanced ultrasound (CEUS) in pregnancy: Is this the last frontier for microbubbles? Ultraschall Med 41(1):8–11
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
VS: project development, data collection, data analysis, manuscript writing/editing, final approval of the manuscript. MFF: data analysis, manuscript editing, final approval of the manuscript. CM: data analysis, manuscript editing, final approval of the manuscript. TK: data analysis (histopathologic analysis), manuscript editing, final approval of the manuscript. JR: project development, data analysis, manuscript editing, final approval of the manuscript. DAC: project development, data collection (every CEUS examination), manuscript editing, final approval of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest to disclose by the authors.
Ethics approval
This retrospective single-center study was approved by the local institutional ethical committee of the institutional review board (Ethics Committee, Medical Faculty, Ludwig-Maximilians-University Munich, project number: 17-087) and all contributing authors followed the ethical guidelines for publication in Archives of Gynecology and Obstetrics. All study data were gathered according to the principles expressed in the Declaration of Helsinki/Edinburgh 2002. Prior to each examination oral and written informed consent of all pregnant patients were given before CEUS examination and their associated risks and potential complications including yet non-described fetal adverse effects have been carefully described.
Informed consent
Informed consent of all included patients to participate in the clinical study during their medical care at our University Hospital was obtained. All included patients agreed that their data might anonymously be published in a scientific journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schwarze, V., Froelich, M.F., Marschner, C. et al. Safe and pivotal approaches using contrast-enhanced ultrasound for the diagnostic workup of non-obstetric conditions during pregnancy, a single-center experience. Arch Gynecol Obstet 303, 103–112 (2021). https://doi.org/10.1007/s00404-020-05735-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05735-8